Chronic GVHD — Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Citation(s)
A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus Plus Prednisone and Sirolimus/Calcineurin Inhibitor Plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease (BMT CTN Protocol #0801)